Potentially missing data are considerably more frequent than definitely missing data: a methodological survey of 638 randomized controlled trials

被引:6
作者
Kahale, Lara A. [1 ]
Diab, Batoul [1 ]
Khamis, Assem M. [1 ]
Chang, Yaping [2 ]
Lopes, Luciane Cruz [3 ]
Agarwal, Arnav [2 ,4 ]
Li, Ling [5 ,6 ]
Mustafa, Reem A. [2 ,7 ,8 ]
Koujanian, Serge [9 ]
Waziry, Reem [10 ]
Busse, Jason W. [2 ,11 ,12 ,13 ]
Dakik, Abeer [1 ]
Guyatt, Gordon [2 ,14 ]
Akl, Elie A. [1 ,2 ]
机构
[1] Amer Univ Beirut, Clin Epidemiol Unit, Beirut, Lebanon
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[3] Univ Sorocaba, UNISO, Pharmaceut Sci Post Grad Course, Sorocaba, SP, Brazil
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Sichuan, Peoples R China
[6] Sichuan Univ, West China Hosp, CREAT Grp, Chengdu, Sichuan, Peoples R China
[7] Univ Missouri, Dept Med, Kansas City, MO 64110 USA
[8] Univ Missouri, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA
[9] Sunnybrook Hlth Sci Ctr, Dept Evaluat Clin Sci, Toronto, ON, Canada
[10] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA USA
[11] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada
[12] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada
[13] McMaster Univ, Michael G DeGroote Ctr Med Cannabis Res, Hamilton, ON, Canada
[14] McMaster Univ, Dept Med, Hamilton, ON, Canada
关键词
Missing data; Follow-up; Reporting; Risk of bias; Randomized controlled trials; Systematic reviews; Meta-analysis; OF-LIFE DATA; OUTCOME DATA; CLINICAL-TRIALS; METAANALYSIS; UNCERTAINTY; QUALITY; CHALLENGES; GUIDELINES; IMPUTATION; STATEMENT;
D O I
10.1016/j.jclinepi.2018.10.001
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and Objective: Missing data for the outcomes of participants in randomized controlled trials (RCTs) are a key element of risk of bias assessment. However, it is not always clear from RCT reports whether some categories of participants were followed-up or not (i.e., do or do not have missing data) nor how the RCT authors dealt with missing data in their analyses. Our objectives were to describe how RCT authors (1) report on different categories of participants that might have missing data, (2) handle these categories in the analysis, and (3) judge the risk of bias associated with missing data. Methods: We surveyed all RCT reports included in 100 clinical intervention systematic reviews (SRs), half of which were Cochrane SRs. Eligible SRs reported a group-level meta-analysis of a patient-important dichotomous efficacy outcome, with a statistically significant effect estimate. Eleven reviewers, working in pairs, independently extracted data from the primary RCT reports included in the SRs. We predefined 19 categories of participants that might have missing data. Then, we classified these participants as follows: "explicitly followed-up," "explicitly not followed-up" (i.e., definitely missing data), or "unclear follow-up status" (i.e., potentially missing data). Results: Of 638 eligible RCTs, 400 (63%) reported on at least one of the predefined categories of participants that might have missing data. The median percentage of participants who were explicitly not followed-up was 5.8% (interquartile range 2.2-14.8%); it was 9.7% (4.1-14.9%) for participants with unclear follow up status; and 11.7% (interquartile range 5.6-23.7%) for participants who were explicitly not followed-up and with unclear follow-up status. When authors explicitly reported not following-up participants, they most often conducted complete case analysis (54%). Most RCTs neither reported on missing data separately for different outcomes (99%) nor reported using a method for judging risk of bias associated with missing data (95%). Conclusion: "Potentially missing data" are considerably more frequent than "definitely missing data." Adequate reporting of missing data will require development of explicit standards on which editors insist and to which RCT authors adhere. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:18 / 31
页数:14
相关论文
共 50 条
  • [41] Missing Data and Measurement Variability in Assessing Progression-Free Survival Endpoint in Randomized Clinical Trials
    Sridhara, Rajeshwari
    Mandrekar, Sumithra J.
    Dodd, Lori E.
    CLINICAL CANCER RESEARCH, 2013, 19 (10) : 2613 - 2620
  • [42] A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes
    Fowzia Ibrahim
    Brian D. M. Tom
    David L. Scott
    Andrew Toby Prevost
    Trials, 17
  • [43] Intention-to-Treat Analysis and Accounting for Missing Data in Orthopedic Randomized Clinical Trials
    Herman, Amir
    Botser, Itamar Busheri
    Tenenbaum, Shay
    Chechick, Ahron
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (09) : 2137 - 2143
  • [44] Missing data frequency and correlates in two randomized surgical trials for urinary incontinence in women
    Linda Brubaker
    Heather J. Litman
    Hae-Young Kim
    Philippe Zimmern
    Keisha Dyer
    John W. Kusek
    Holly E. Richter
    Anne Stoddard
    International Urogynecology Journal, 2015, 26 : 1155 - 1159
  • [45] Treatment of missing data in follow-up studies of randomised controlled trials: A systematic review of the literature
    Sullivan, Thomas R.
    Yelland, Lisa N.
    Lee, Katherine J.
    Ryan, Philip
    Salter, Amy B.
    CLINICAL TRIALS, 2017, 14 (04) : 387 - 395
  • [46] Attrition, missing data, compliance, and related biases in randomized controlled trials of rehabilitation interventions: towards improving reporting and conduct
    Armijo-Olivo, Susan
    Machalicek, Wendy
    De Oliveira-Souza, Ana, I
    Dennett, Liz
    Ballenberger, Nikolaus
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2020, 56 (06) : 817 - 828
  • [47] Poor reporting quality and high proportion of missing data in economic evaluations alongside pragmatic trials: a cross-sectional survey
    Xin, Yu
    Song, Ruomeng
    Hao, Jun
    Li, Wentan
    Wu, Changjin
    Zuo, Ling
    Cai, Yuanyi
    Zhang, Xiyan
    Wu, Huazhang
    Hui, Wen
    BMC MEDICAL RESEARCH METHODOLOGY, 2025, 25 (01)
  • [48] Is Personality a Key Predictor of Missing Study Data? An Analysis From a Randomized Controlled Trial
    Jerant, Anthony
    Chapman, Benjamin P.
    Duberstein, Paul
    Franks, Peter
    ANNALS OF FAMILY MEDICINE, 2009, 7 (02) : 148 - 156
  • [49] Comparison of Missing Data Reporting and Handling in Randomized Controlled Trials of Rheumatoid Arthritis Drug Therapy: A Snapshot Ten Years Apart
    Aslam, Fawad
    Torralba, Karina
    Khan, Nasim A.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [50] Handling missing data in cluster randomized trials: A demonstration of multiple imputation with PAN through SAS
    Zhou, Jiangxiu
    Connell, Lauren E.
    Graham, John W.
    QUANTITATIVE METHODS FOR PSYCHOLOGY, 2014, 10 (02): : 153 - 166